Oncologists fight leukemia with two-pronged therapy, clinical trials planned
Friday, June 4, 2010 - 22:31
in Health & Medicine
Researchers have used an agent, called Oxi4503, to poison leukemia cells and destroy the blood vessels that supply the cells in mouse models of acute myelogenous leukemia, or AML. The researchers plan human tests of the drug later this year.